Spyre Therapeutics
SYRE
SYRE
131 hedge funds and large institutions have $1.39B invested in Spyre Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 20 reducing their positions, and 21 closing their positions.
Holders
131
Holders Change
+12
Holders Change %
+10.08%
% of All Funds
1.74%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
34
Increased
63
Reduced
20
Closed
21
Calls
$161K
Puts
$79K
Net Calls
+$82K
Net Calls Change
+$102K
Top Buyers
1 |
DCM
1
Driehaus Capital Management
Chicago,
Illinois
|
$65.3M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$205M |
3 |
JFG
3
Jefferies Financial Group
New York
|
$28.3M |
4 |
4
BlackRock
New York
|
$79.1M |
5 |
5
Goldman Sachs
New York
|
$17.4M |